Pharmacocinétique des médicaments cardiovasculaires chez la personne âgée.

Moore, 1996, Effets indésirables des médicaments chez la personne âgée: une analyse de la banque nationale de cas en pharmacovigilance, Rev. Prat., 46, 396 Tumer, 1992, Geriatric pharmacology: basis and clinical considerations, Ann. Rev. Pharmacol. Toxicol., 32, 271, 10.1146/annurev.pa.32.040192.001415 Richey, 1977, Pharmacokinetic consequences of aging, Ann. Rev. Pharmacol. Toxicol., 17, 49, 10.1146/annurev.pa.17.040177.000405 Pucino, 1985, Pharmacogeriatrics, Pharmacotherapy, 5, 314, 10.1002/j.1875-9114.1985.tb03437.x Charmes, 1996, Les conséquences du vieillissement rénal en thérapeutique, Revue de Gériatrie, 21, 447 Teillet, 1999, Vieillissement rénal: mécanismes cellulaires des troubles de l’équilibre hydrique, Thérapie, 54, 147 Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron., 16, 31, 10.1159/000180580 National Kidney Foundation, 2002, The kidney disease outcomes quality initiatives. Clinical practices guidelines for chronic kidney disease: evaluation, classification, stratification, Am. J. Kidney Dis., 39, S1 Swift, 1978, A study of antipyrine in relation to liver size in the elderly, Eur. J. Clin. Pharmacol., 14, 149, 10.1007/BF00607447 George, 1995, Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver, Biochem Pharmacol., 50, 727, 10.1016/0006-2952(95)00192-3 Hunt, 1992, Human hepatic cytochrome P450 3A4 activity in the elderly, Mech. Ageing. Dev., 64, 189, 10.1016/0047-6374(92)90106-N Kinirons, 2004, Drug metabolism an ageing, Br. J. Clin. Pharmacol., 57, 540, 10.1111/j.1365-2125.2004.02096.x Thiessard, 2005, Trends in spontaneous adverse drug reactions reports to French pharmacocivigilance system, Drug Saf., 28, 731, 10.2165/00002018-200528080-00007 Queneau, 2003, Effets indésirables médicamenteux observés dans des services d’accueil et d’urgence français, Bull. Acad. Natl. Med., 187, 647 Imbs, 1999, Iatrogénic médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français, Thérapie, 54, 21 Pouyanne, 2000, Admissions to hospital caused by adverse drug reactions: cross sectional incidence study, BMJ, 320, 1036, 10.1136/bmj.320.7241.1036 Pirmohame, 2004, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ, 329, 15, 10.1136/bmj.329.7456.15 Nicholls, 1988, Age-related effects of diuretics in hypertensive subjects, J. Cardiovasc. Pharmacol., 12, S51, 10.1097/00005344-198812081-00012 Gar, 1997, The effect of digoxin on mortality and morbidity in patients with heart failure, N. Engl. J. Med., 336, 525, 10.1056/NEJM199702203360801 Adams, 2005, Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial, J. Am. Coll. Cardiol., 46, 497, 10.1016/j.jacc.2005.02.091 Martin-Facklam, 2004, Undeclared exposure to St John’s Wort in hospitalized patients, Br. J. Clin. Pharmacol., 58, 437, 10.1111/j.1365-2125.2004.02169.x Lip, 2006, Antithrombotic treatment in atrial fibrillation, Heart, 92, 155, 10.1136/hrt.2005.071555 Gonther, 1999, Polypathologies du sujet âgé et réponses thérapeutiques: les pièges à éviter, La Presse Médicale, 28, 1780 Haute Autorité de Santé. — Prescription médicamenteuse chez le sujet âgé. Programme d’évaluation et d’amélioration des pratiques professionnelles: http://www.has-sante.fr (rubrique « nouveautés »). AFSSaPS — Mise au point. Prévenir la iatrogenèse médicamenteuse chez le sujet âgé. Bon usage. www.afssaps.sante.fr. Fialova, 2005, Potentially inappropirate modication use among elderly home care patients in Europe, JAMA, 293, 1348, 10.1001/jama.293.11.1348 Higashi, 2004, The quality of pharmacologic care for vulnerable older patients, Ann. Intern. Med., 140, 714, 10.7326/0003-4819-140-9-200405040-00011 Beers, 1997, Explicit criteria for determinating inappropriate medication use by the elderly: an update, Arch. Int. Med., 157, 1531, 10.1001/archinte.1997.00440350031003 Cournot, 2005, Motifs de sous- utilisation des thérapeutiques de prévention secondaire chez les coronariens de plus de 70 ans, Annales de Cardiologie et d’Angéiologie, 54, S17